[ad_1]
SEBI has proposed easing norms for NRIs within the derivatives market. It suggests utilizing PAN as a novel identifier to observe place limits, eliminating the necessity for CP Codes and the restriction to cope with just one clearing member. Public feedback on this session paper are open till December 31, 2024.
Moneycontrol – 10 Dec 24
SEBI proposes easing norms for NRIs in FnO section, suggests utilizing PAN as…
In a session paper issued on December 10, the regulator proposed taking out the CP Code
SEBI has introduced that an non-obligatory T+0 settlement cycle shall be accessible for the highest 500 shares by market cap from December 31, 2024. Brokers can cost differential charges for T+0 and T+1 cycles. The mechanism consists of block deal home windows and operational tips to make sure easy implementation.
Moneycontrol – 10 Dec 24
Optionally available T+0 settlement cycle shall be made accessible to high 500 shares from…
Inventory brokers are permitted to cost differential brokerage for T+0 and T+1 settlement cycles, inside regulatory restrict, says SEBI
India’s drug regulator has proposed fast-tracking approvals and waiving native scientific trials for uncommon illness medicine to enhance availability. State regulators have been directed to course of approvals inside 90 days, facilitate imports, and prioritize testing of uncommon illness medicine. Waivers can also apply to gene therapies, pandemic medicine, and defense-related medicine permitted in main international markets.
1 Like
[ad_2]
Source link
